Modelling the long QT syndrome with induced pluripotent stem cells
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Items 801–900 of 1,000
Vascular research using human pluripotent stem cells and humoral factors [Review]
Sone, M., & Nakao, K. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0020 · Cited by 3
Kaur, K. K., & Allahbadia, G. (2016) · Transcriptomics Open Access · doi:10.4172/2329-8936.1000134 · Cited by 3
Human Pluripotent Stem Cell‐Derived Cardiomyocytes
Shukla, P., Garg, P., & Wu, J. C. (2016) · Wiley eBooks · doi:10.1002/9781119053248.ch22 · Cited by 3
Advances in Umbilical Cord Blood Therapy: Hematopoietic Stem Cell Transplantation and Beyond
Chow, T., Mueller, S., & Rogers, I. M. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-29149-9_8 · Cited by 3
Amniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases
Stuppia, L., Antonucci, I., & Crowley, M. G. (2017) · Brain Circulation · doi:10.4103/bc.bc_23_17 · Cited by 3
Schwartz, P. J., & Crotti, L. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00093-5 · Cited by 3
Human iPSC models of cardiac electrophysiology and arrhythmia
Yang, B., Lowenthal, J., Tomaselli, G. F., & Tung, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85767-3.00006-2 · Cited by 5
Rao, M. S. (2013) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400127.pub2 · Cited by 3
Henze, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6012 · Cited by 4
Nagashima, T., Miki, K., Tsuchida, M., Whitehouse, J., Sasozaki, I. T., Higashiyama, Y., Ishida, H., Kashino, K., & Miyagawa, S. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70108 · Cited by 2
Induced pluripotent stem cells from discovery to translation
Lee, J., Herron, T. J., Studer, L., Mummery, C. L., & Wu, J. C. (2026) · Nature Medicine · doi:10.1038/s41591-026-04584-3 · Cited by 3
Modelling of Genetic Cardiac Diseases
Prajapati, C., & Aalto‐Setälä, K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84965 · Cited by 2
Pang, L. K., Huang, M.-F., Gingold, J. A., Pena, M., Zhao, R., & Lee, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85767-3.00004-9 · Cited by 3
Ireland, J., & Kilian, K. A. (2024) · Matrix Biology Plus · doi:10.1016/j.mbplus.2024.100160 · Cited by 3
Evidence for Renal Progenitors in the Human Kidney
Lasagni, L., Lazzeri, E., Peired, A. J., & Romagnani, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800102-8.00029-1 · Cited by 2
Utility of Human Stem Cells for Drug Discovery
Chintawar, S., Graf, M. R., & Cader, M. Z. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620136-00162 · Cited by 2
Sakamoto, T., Nishimura, K., Ohnishi, H., & Iki, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54862-1_31 · Cited by 2
Azizi, H., Moghaddam, A. H., & Skutella, T. (2015) · Wiley eBooks · doi:10.1002/9781118540640.ch2 · Cited by 2
Ikeuchi, T., Espulgar, W. V., Shimizu, E., Saito, M., Lee, J., Dou, X., Yamaguchi, Y., & Tamiya, E. (2015) · The Analyst · doi:10.1039/c5an01144b · Cited by 2
Modeling Hereditary Cardiac Disease With Patient-specific-induced Pluripotent Stem Cells
Ng, K., & Tse, H. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31825f3f0f · Cited by 2
Inherited Arrhythmias: Of Channels, Currents, and Swimming
Zylla, M. M., & Thomas, D. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.02.010 · Cited by 2
Modeling Cardiac Congenital Diseases: From Mathematic Tools to Human Induced Pluripotent Stem Cells
Iop, L. (2014) · Conference Papers in Science · doi:10.1155/2014/369246 · Cited by 2
Modeling Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy with Patient-Specific iPSCs
Shah, K., Wei, C.-Y., Kim, C.-S., Wong, J., Wen, J., Tirasawasdichai, T., Wang, C., & Chen, H.-S. V. (2016) · Springer eBooks · doi:10.1007/978-4-431-55966-5_3 · Cited by 3
State of the Art in Cardiomyocyte Transplantation
Hartman, M. E., Chong, J. J. H., & Laflamme, M. A. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-56106-6_9 · Cited by 2
Dirschinger, R. J., Dorn, T., & Moretti, A. (2019) · Cardiac and vascular biology · doi:10.1007/978-3-030-27371-2_10 · Cited by 2
Sharma, A. (2020) · Science · doi:10.1126/science.aba6111 · Cited by 2
Lodola, F., Giusti, V. C. D., Maniezzi, C., Martone, D., Stadiotti, I., Sommariva, E., & Maione, A. S. (2021) · Biology · doi:10.3390/biology10080730 · Cited by 3
Heijman, J. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120427jh · Cited by 3
Restoring the resting potential brings maturity to induced stem cell–derived human cardiac myocytes
Clusin, W. T. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.10.015 · Cited by 3
Callaway, E. (2011) · Nature · doi:10.1038/news.2011.232 · Cited by 2
Wu, Y., Kong, X.-J., Ji, Y.-Y., Fan, J., Chen, X., Ji, C., Cheng, Y., & Wu, S. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.113929 · Cited by 2
A study on the maturation of cardiomyocytes by continuous supply of culture media
Kwon, W., Kim, G. W., 정운선, Kim, J., & Lee, D. (2021) · Journal of Sensor Science and Technology · doi:10.46670/jsst.2021.30.2.109 · Cited by 1
Optimizing the Differentiation of Cardiomyocytes from Human Induced Pluripotent-Derived Stem Cells
Gartz, M., & Strande, J. L. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1480-8_6 · Cited by 1
Drug Discovery in Induced Pluripotent Stem Cell Models
Bourque, K., Mnasri, N., Jones-Tabah, J., Martins-Cannavino, K., & Hébert, T. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00049-9 · Cited by 1
Strategies for Mimicking Extracellular Matrix
Hélary, C. (2024) · Springer eBooks · doi:10.1007/978-3-030-92090-6_9-1 · Cited by 2
Cardiovascular precision and personalised medicine
Kumar, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822951-4.00017-5 · Cited by 2
Correlation in Stem Cell Technology, Tissue Engineering, and Regenerative Medicine
Bharti, S., & Kumar, A. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00388-y · Cited by 5
Verkerk, A. O., Veerman, C. C., Hoekstra, M., Devalla, H. D., & Wilders, R. (2025) · Cells · doi:10.3390/cells14161226 · Cited by 1
Barbieri, M., Casini, S., Louradour, J., de Waal, T. M., Alerni, N., Verkerk, A. O., Giannetti, F., Sala, L., Sager, P. T., Das, S., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108189 · Cited by 1
Self-citationDeBose, M., Choi, J., Ding, D., Griggs, A., Gollatz, E. M., Scislowicz, E., Harbuzariu, A., & Itzhaki, I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083588 · Cited by 1
Self-citationModeling ventricular tachycardia in genetic long QT syndrome using engineered cardiac tissues
Zhuang, R. Z., Doufexi, G., Yehya, M., Morsink, M. A. J., Liao, X., Ben-Johny, M., & Vunjak‐Novakovic, G. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.04.032 · Cited by 1
Therapeutic Approaches in Regenerative Medicine of Cardiovascular Diseases: From Bench to Bedside
Aránega, A., Bustamante, M., Juan, A., Perán, M., Lopez, E., Alvarez, P. J., Rodríguez‐Serrano, F., & Carrillo, E. (2011) · InTech eBooks · doi:10.5772/25534 · Cited by 1
The Hope for iPSC in Lung Stem Cell Therapy and Disease Modeling
Menon, T., & Firth, A. L. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-16232-4_7 · Cited by 1
Induced Pluripotent Stem Cells for Cardiac Regeneration
Madonna, R., Ferdinandy, P., & Schulz, R. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-25427-2_3 · Cited by 2
Cell Programming for Future Regenerative Medicine
Hausburg, F., & David, R. (2016) · Springer eBooks · doi:10.1007/978-3-319-27610-6_15 · Cited by 1
(2012) · Asia-Pacific Biotech News · doi:10.1142/s0219030312000183 · Cited by 1
Advances in Induced Pluripotent Stem Cell Biology
Seifinejad, A. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-940-2_5 · Cited by 1
Heffernan, C., Liu, J., Sümer, H., Malaver-Ortega, L. F., Verma, R., Carvalho, E. J., & Verma, P. J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6621-1_2 · Cited by 1
Generation of Patient Specific Stem Cells: A Human Model System
Simonsson, S., Boreström, C., & Asp, J. (2012) · InTech eBooks · doi:10.5772/35918 · Cited by 1
High‐Throughput Screening Assays to Evaluate the Cardiotoxic Potential of Drugs
Mandenius, C., & Meyer, T. S. (2013) · Wiley eBooks · doi:10.1002/9781118538203.ch22 · Cited by 1
Human Pluripotent Stem Cell-Derived Cardiomyocytes: Maturity and Electrophysiology
Kujala, V. J., Pekkanen-Mattila, M., & Aalto‐Setälä, K. (2011) · InTech eBooks · doi:10.5772/24625 · Cited by 1
Human Stem‐Cell‐Derived Cardiomyocytes in Drug Discovery and Toxicity Testing
Szebényi, K., Péntek, A., Varga, N., Erdei, Z., Vőfély, G., Orbán, T. I., Sarkadi, B., & Apáti, Á. (2014) · Wiley eBooks · doi:10.1002/9781118856017.ch15 · Cited by 1
Adult Cardiac Stem Cells: Identity, Location and Potential
Ellison, G. M., Smith, A. J., Waring, C. D., Henning, B. J., Burdina, A. O., Polydorou, J., Vicinanza, C., Lewis, F., Nadal‐Ginard, B., & Torella, D. (2013) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4614-9569-7_4 · Cited by 2
Converting Scar to Muscle in the Injured Heart
Riley, P. R. (2012) · Molecular Therapy · doi:10.1038/mt.2012.121 · Cited by 1
Automatisierte Kultivierung von induziert pluripotenten Stammzellen
Meiser, I., Sébastien, I., & Neubauer, J. C. (2013) · BIOspektrum · doi:10.1007/s12268-013-0351-8 · Cited by 1
The Paradigm of Systems Biology Applied to Cardiovascular Diseases
Mesquita, E. T., Silva, E. N., Jorge, A. J. L., Mariano, B. D. M., Cassino, J. P. P., Souza, C. V., Mesquita, M. A., & Rocha, R. G. (2015) · International Journal of Cardiovascular Sciences · doi:10.5935/2359-4802.20150011 · Cited by 2
Induced Pluripotent Stem Cells: To Model, To Treat
Wang, H. (2011) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000e103 · Cited by 1
Human Pluripotent Stem Cells and Drug Discovery: A New Beginning
Verma, V., Mehta, A. K., & Flora, S. J. S. (2016) · Defence Life Science Journal · doi:10.14429/dlsj.1.10060 · Cited by 1
Regulations of Regenerative Medicine Including Clinical Application of iPS Cells in Japan
Inoue, H., & Tsuruyama, T. (2016) · International Journal of Stem Cell Research and Transplantation · doi:10.19070/2328-3548-1600029 · Cited by 1
Lead Generation for Challenging Targets
Wan, J., Dou, D., Song, H., Cheng, X. W. X., & Li, J. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677047.ch10 · Cited by 2
Innovation and Commercialisation of Induced Pluripotent Stem Cells
Sengoku, S. (2015) · Wiley eBooks · doi:10.1002/9781118846193.ch24 · Cited by 1
Micro/Nano Cell Potential Biosensors
Fang, J., Wang, Q. L., & Hu, N. (2016) · Springer eBooks · doi:10.1007/978-981-10-1658-5_5 · Cited by 1
Woon, M. T., & Kamp, T. J. (2017) · eLife · doi:10.7554/elife.24276 · Cited by 1
Stem Cells in Regenerative Medicine: Prospects and Pitfalls
Zehravi, M., Shahid, O., Ghauri, A. K., Ghori, F. F., & Wahid, M. (2017) · National Journal of Health Sciences · doi:10.21089/njhs.23.0116 · Cited by 1
Human iPSCs and their uses in developmental toxicology
Edenfield, R. C., Siracusa, J. S., Wang, R., & Yu, X. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822228-7.00012-6 · Cited by 1
Model Systems for Addressing Mechanism of Arrhythmogenesis in Cardiac Repair
Zhang, X.-D., Thai, P. N., Lieu, D. K., & Chiamvimonvat, N. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01498-z · Cited by 1
Stem Cell Therapy to Treat Heart Failure
Gara, E., Kosztin, A., Harding, S. E., & Földes, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64046-8.00302-5 · Cited by 1
Yarmohammadi, R., Ghollasi, M., Kheirollahzadeh, F., Soltanyzadeh, M., Heshmati, M., & Amirkhani, M. A. (2022) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-022-00652-3 · Cited by 1
Muñoz, D. R., Martin, D., & Gómez, J. L. Z. (2017) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2017.07.001 · Cited by 1
Lin, L. Y., Barszczewski, T., Burgon, P. G., & Tibbits, G. F. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_44 · Cited by 1
Natural Biomaterials: An Essential Element for in vitro Disease Modeling
Gayan, S., Chitnis, M. S., Kshirsagar, D., & Dey, T. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136869124010007 · Cited by 1
Chen, C., Wu, J., Qin, C., Qiu, Y. L., Jiang, N., Wang, Q., Liu, M., Jiang, D., Yuan, Q., Wei, X., et al. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-00985-5 · Cited by 1
Induced Pluripotent Stem Cells Differentiate into Functional Cardiomyocytes
Olmer, R., & Martin, U. (2013) · Stem cells and cancer stem cells · doi:10.1007/978-94-017-8032-2_5 · Cited by 1
Advances in Induced Pluripotent Stem Cell Technologies
Pal, R., Rao, M. S., Vemuri, M. C., Verma, P. J., & Dinnyés, A. (2012) · Stem Cells International · doi:10.1155/2012/850201 · Cited by 1
Virus-free iPS-derived cardiomyocytes: a new piece in the puzzle of patient-tailored therapies
Barbuti, A. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr199 · Cited by 1
Long QT Syndrome: From Genetic Basis to Treatment
Crotti, L., Dagradi, F., & Schwartz, P. J. (2011) · Cardiogenetics · doi:10.4081/cardiogenetics.2011.s1.e2 · Cited by 1
Células-tronco pluripotentes induzidas para o estudo e tratamento da anemia falciforme
Reis, L. C. J. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2017.tde-03072017-102445 · Cited by 4
Sequencing of uncertain significance
Donahue, J. K. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13384 · Cited by 1
Regulation of glucose transport in cardiomyocytes
Bowman, P. R. T. (2019) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.41002 · Cited by 2
Modeling lung cell development using human pluripotent stem cellsPreprint
Wong, A. P. (2021) · Research Square · doi:10.21203/rs.3.rs-753708/v1 · Cited by 1
Induced Pluripotent Stem Cells
Takahashi, K., & Yamanaka, S. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100023 · Cited by 1
Prime Time for Doxorubicin-Induced Cardiotoxicity Genetic Testing
Magdy, T., & Burridge, P. W. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0032 · Cited by 1
Tatekoshi, Y., Chen, C., Shapiro, J. S., Chang, H., Blancard, M., Burridge, P. W., Burridge, P. W., Feinstein, M. J., D’Aquila, R. T., Hsue, P. Y., et al. (2024) · eLife · doi:10.7554/elife.95867.1 · Cited by 1
Human pluripotent stem cells (hPSCs) for heart regeneration
Abilez, O. J., & Wu, J. C. (2014) · Elsevier eBooks · doi:10.1533/9780857096708.3.297
Clinical application progress of induced pluripotent stem cells (iPSCs)
HUANG, C., Jiang, S., & Peng, J. (2014) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/972013-894
Индуцированные плюрипотентные стволовые клетки как модель для изучения болезней человека
Nekrasov, E. D., Lagarkova, M. A., & Киселев, С. Л. (2011) · Genes and Cells
Fatima, A. (2011) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Haviland, S. S. (2013) · DigitalGeorgetown (Georgetown University Library)
Synthetic Biology-Based Approaches to Enhance Transgene Attributes
Chakraborty, S. (2014) · DukeSpace (Duke University)
Integrated Risk Assessment of Cardiovascular Safety in Drug Discovery
Erdemli, G., & Martin, R. L. (2014) · Wiley eBooks · doi:10.1002/9781118783344.ch18
Paavola, J. (2014) · Helda - University of Helsinki Institutional Repository
Disease Models for the Genetic Cardiac Diseases
Pekkanen-Mattila, M., Rajala, K., & Aalto‐Setälä, K. (2013) · InTech eBooks · doi:10.5772/55773
Phenotypic Correlation of Genetic Mutations with Ventricular Arrhythmias
Krishnan, Y., Chen, J., & McDonald, T. V. (2012) · InTech eBooks · doi:10.5772/32342
Reis, L. C. J. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2012.tde-26022013-092913 · Cited by 1
Directed Cardiomyogenesis of Pluripotent Stem Cells
Bylund, J. B., & Hatzopoulos, A. K. (2014) · Wiley eBooks · doi:10.1002/9781118695746.ch2
Human Stem Cell Models of Neurodevelopmental Disorders
Kirwan, P., & Livesey, F. J. (2015) · Wiley eBooks · doi:10.1002/9781118524947.ch10
Benjamin, I. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00048-3
Wiring the developing heart: a serious matter for adulthood
Franco, D. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs341
Multifactorial Impact of Channel Beta‐Subunit Gene Mutation on Automaticity
DiFrancesco, D., Nawathe, P. A., & Robinson, R. B. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12235
Application of Induced Pluripotent Stem Cells in Rheumatology
Jung, S. M., & Ju, J. H. (2013) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2013.20.5.286
Metadata
- Authors
- Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gepstein, Lior
- Venue
- Nature
- Published
- 2011-01-16
- Volume
- 471
- Issue
- 7337
- Pages
- 225-229
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2115644752
- Cited by
- 1,049
- References
- 28
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
- FWCI
- 86.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
- MeSH terms
- ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.